Human Longevity
San Diego, US · Delaware corporation · 2 known investors
Biotech
Founders & leadership
DK
David KarowExecutive Officer, Director
JH
James HuExecutive Officer, Director
WH
Wei-Wu HeDirector
JH
James HuangDirector
HS
Helmut SchuehslerDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$32MraisedAug 2024 · 18 investors · BiotechnologyRule 506(b)
▶$32MraisedAug 2024 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- James HuangDirector
- Helmut SchuehslerDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedOct 2022 · 11 investors · BiotechnologyRule 506(b)
▶$6.9MraisedOct 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $11.7M
- Amount sold
- $6.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$20.1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David KarowExecutive Officer, Director
- Wei-Wu HeDirector
- James HuDirector
- Offering amount
- $30M
- Amount sold
- $20.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Genetics Startup 'Human Longevity' Valuation Drops from 1.6B to 310Mmedcitynews.com · 2019
